Nix Biosensors
Nix Biosensors Raises $10M Series A for Hydration Intelligence
Nix Biosensors announced $10M in Series A financing on September 15, 2026. Nix Biosensors closed a $10 million Series A to develop Nix Health and bring personalized hydration data into consumer-health platforms.
Round details
The financing includes backing from Shorewind Capital, Great Oaks Venture Capital, White Road Investments, Anne Wojcicki. The company did not publish a valuation with the announcement.
- Round: Series A
- Capital announced: $10M
- Total funding reported: $17M
- Headquarters: Boston, MA
How the company plans to use the capital
Nix will fund product development, data science, and market expansion, with a focus on Nix Health algorithms that can be licensed into existing consumer-health platforms without requiring a sweat sensor.
Why this matters for GTM teams
The financing points to a broader commercialization path for wearable data: converting proprietary real-world datasets into software intelligence that can travel across consumer-health platforms.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Nix Biosensors Series A announcement.
Company Info
Investors (4)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free